StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 0.1 % NASDAQ PIRS opened at $10.48 on Thursday. The business’s 50-day moving average price is $12.87 and […]
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 2.8 % NASDAQ:PIRS opened at $0.18 on Friday. The stock’s 50 day moving average price is $0.21 and its two-hundred day […]
Silverarc Capital Management LLC Acquires New Position in Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Research analysts at StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, William Blair cut Pieris Pharmaceuticals from an “outperform” rating to a “market perform” rating in a research note on Wednesday, […]